What we’re reading: the FDA versus 23andME

Bear reading book

In the journals

Caulfield T, Evans J, McGuire A, McCabe C, Bubela T, et al. (2013) Reflections on the Cost of “Low-Cost” Whole Genome Sequencing: Framing the Health Policy Debate. PLoS Biol 11(11): e1001699. doi:10.1371/journal.pbio.1001699

Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us about potential benefits and harms, particularly in the context of health care policy.

In the news

The personal genotyping service by 23andMe got smacked down by the U.S. FDA; but it probably won’t slow down the rush to consumer genomics.

Share

About Jeremy Yoder

Jeremy Yoder is an Assistant Professor of Biology at California State University, Northridge. He also blogs at Denim and Tweed, and tweets under the handle @jbyoder.
This entry was posted in linkfest. Bookmark the permalink.